Investment Agreements in the Biotechnology Industry

97 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Capital Provision Agreement dated as of December 11, 2020 between the Company and Epps Investments LLC
Investment Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2021
Subscription and Investment Representation Agreement, dated August 7, 2024, by and between Pieris Pharmaceuticals, Inc. and James Geraghty
Investment Agreements
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NV
2024
Form of Subscription and Investment Representation Agreement, dated May 29, 2024
Investment Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2024
Amendment Agreement, dated May 16, 2024, by and between OpGen, Inc. and the European Investment Bank
Investment Agreements
OPGEN INC
Biotechnology
2024
Subscription and Investment Representation Agreement, dated April 23, 2024, by and between Panbela Therapeutics, Inc. and Michael T. Cullen
Investment Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2024
Accession, Amendment and Restatement Agreement to the Finance Contract relating to the Finance Contract dated 24 July 2020, as amended from time to time, by and between the...
Investment Agreements
Cortexyme, Inc.
Biotechnology
CA
2024
Investment Agreement, dated as of April 1, 2024, by and among Rhythm Pharmaceuticals, Inc., and the investors named therein
Investment Agreements
RHYTHM PHARMACEUTICALS, INC.
Biotechnology
NY
2024
Investment Agreement, dated March 4, 2024
Investment Agreements
Isoray, Inc.
Biotechnology
DE
2024
Form of Investment Agreement
Investment Agreements
CRISPR Therapeutics AG
Biotechnology
NY
2024
Investment Agreement, dated as of January 8, 2024, by and among Perspective Therapeutics, Inc. and Lantheus Alpha Therapy, LLC
Investment Agreements
Isoray, Inc.
Biotechnology
DE
2024
Investment Agreement, dated October 30, 2023, by and among MeiraGTx Holdings plc, Sanofi Foreign Participations B.V. and Sanofi
Investment Agreements
MeiraGTx Holdings plc
Biotechnology
NY
2023
Amendment to the Investment Agreement, dated as of July 18, 2023, between Santhera and the Company
Investment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2023
Subscription and Investment Representation Agreement, dated July 11, 2023, by and between Aditxt, Inc., and the purchaser signatory thereto
Investment Agreements
ADiTx Therapeutics, Inc.
Biotechnology
DE
2023
Investment Agreement, dated as of June 19, 2023, by and between Santhera and the Company (certain identified information has been excluded from the exhibit because it both (i) is...
Investment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2023
Subscription and Investment Representation Agreement, dated April 14, 2023, by and between Panbela Therapeutics, Inc. and Michael T. Cullen
Investment Agreements
Sun BioPharma, Inc.
Biotechnology
DE
2023
Investment Agreement, dated December 22, 2022, by and between the Registrant and Batiste Investments LLC
Investment Agreements
Tracon Pharmaceuticals, Inc.
Biotechnology
2023
Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto
Investment Agreements
CYTORI THERAPEUTICS, INC.
Biotechnology
DE
2023
Subscription and Investment Representation Agreement, dated December 19, 2022, by and between Revelation Biosciences, Inc. and the purchaser signatory thereto
Investment Agreements
Petra Acquisition Inc.
Biotechnology
DE
2022
Subscription and Investment Representation Agreement, dated December 1, 2022, by and between Advaxis, Inc. and the purchaser signatory thereto
Investment Agreements
Advaxis, Inc.
Biotechnology
DE
2022
Subscription and Investment Representation Agreement, dated November 16, 2022, by and between Phio Pharmaceuticals Corp. and the purchaser signatory thereto
Investment Agreements
Phio Pharmaceuticals Corp.
Biotechnology
DE
2022
Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2022
Subscription and Investment Representation Agreement, dated July 19, 2022, by and between Aditxt, Inc.. and the purchaser signatory thereto
Investment Agreements
ADiTx Therapeutics, Inc.
Biotechnology
DE
2022
Form of Subscription and Investment Representation Agreement dated July 12, 2022
Investment Agreements
Allena Pharmaceuticals, Inc.
Biotechnology
DE
2022
Form of Umbrella Agreement Regarding Family Investments
Investment Agreements
GENELUX CORP
Biotechnology
2022
Subscription and Investment Representation Agreement, dated May 25, 2022, by and between Brickell Biotech, Inc. and the purchaser signatory thereto
Investment Agreements
VICAL INC
Biotechnology
DE
2022
Investment Agreement between Akebia Therapeutics, Inc. and Vifor (International) Ltd., dated February 18, 2022
Investment Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2022
Amendment No. 1 to Co-Development Agreement between the Registrant and BXLS V Bodyguard PCP L.P. and BXLS Family Investment Partnership V ESC L.P. dated November 23, 2021
Investment Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2022
Investment Agreement, dated as of January 3, 2022, by and among Aravive, Inc., Eshelman Ventures, LLC, and solely for purposes of Article IV and V of the Investment Agreement,...
Investment Agreements
Aravive, Inc.
Biotechnology
DE
2022
Amendment to Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc., dated August 2, 2021
Investment Agreements
Pyxis Oncology, Inc.
Biotechnology
2021
Opt-In, Investment and Additional Consideration Agreement between Pyxis Oncology, Inc. and LegoChem Biosciences, Inc
Investment Agreements
Pyxis Oncology, Inc.
Biotechnology
MA
2021
Exit Fee Agreement, dated as of April 14, 2021 by and among Rezolute, Inc., Solar Investment Corp., as collateral agent and lender, and the other lenders named therein
Investment Agreements
Rezolute, Inc.
Biotechnology
NY
2021
Sponsor Support Agreement, dated as of March 22, 2021, by and among Chardan Healthcare Acquisition 2 Corp., Chardan Investments 2, LLC and Renovacor, Inc
Investment Agreements
Chardan Healthcare Acquisition 2 Corp.
Biotechnology
2021
Form of Letter Agreement among the Registrant and our officers, directors, CG Investments Inc. VI and HB Strategies LLC
Investment Agreements
Environmental Impact Acquisition Corp
Biotechnology
DE
2021
Securities Subscription Agreement, dated August 14, 2020, between the Registrant and CG Investments Inc. VI
Investment Agreements
Environmental Impact Acquisition Corp
Biotechnology
NY
2020
Tender and Support Agreement, dated December 14, 2020, by and among Eli Lilly and Company, Tyto Acquisition Corporation, OrbiMed Private Investments VI, LP
Investment Agreements
Prevail Therapeutics Inc.
Biotechnology
DE
2020
Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020
Investment Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Subscription Agreement, dated October 7, 2020, between the Company and Petra Investment Holdings LLC
Investment Agreements
Petra Acquisition Inc.
Biotechnology
2020
Investment Agreement, dated as of September 1, 2020, by and between the Registrant and Icahn Capital LP
Investment Agreements
ENZON PHARMACEUTICALS, INC.
Biotechnology
DE
2020
INVESTMENTAGREEMENT BYAND BETWEEN ENZONPHARMACEUTICALS, INC. AND ICAHNCAPITAL LP DATEDAS OF SEPTEMBER 1, 2020
Investment Agreements
ENZON PHARMACEUTICALS, INC.
Biotechnology
DE
2020
Form of Subscription Agreement for Private Warrants by Petra Investment Holdings, LLC
Investment Agreements
Petra Acquisition Inc.
Biotechnology
2020